dopa < dopamine < dopaminergic

Facettes :

List of bibliographic references indexed by dopamine

Number of relevant bibliographic references: 356.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000029 (2017)	Daryl J. Wile [Canada] ; Pankaj A. Agarwal [Inde] ; Michael Schulzer [Canada] ; Edwin Mak [Canada] ; Katherine Dinelle [Canada] ; Elham Shahinfard [Canada] ; Nasim Vafai [Canada] ; Kazuko Hasegawa [Japon] ; Jing Zhang [États-Unis] ; Jessamyn Mckenzie [Canada] ; Nicole Neilson [Canada] ; Audrey Strongosky [États-Unis] ; Ryan J. Uitti [États-Unis] ; Mark Guttman [Canada] ; Cyrus P. Zabetian [États-Unis] ; Yu-Shin Ding [États-Unis] ; Mike Adam [Canada] ; Jan Aasly [Norvège] ; Zbigniew K. Wszolek [États-Unis] ; Matthew Farrer [Canada] ; Vesna Sossi [Canada] ; A Jon Stoessl [Canada]	Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
000033 (2017)	Lei Xing [Canada] ; Maddie J. Venables [Canada] ; Vance L. Trudeau [Canada]	Role of aromatase and radial glial cells in neurotoxin-induced dopamine neuron degeneration and regeneration.
000066 (2017)	Kelly M. Lohr [États-Unis] ; Shababa T. Masoud [Canada] ; Ali Salahpour [Canada] ; Gary W. Miller [États-Unis]	Membrane transporters as mediators of synaptic dopamine dynamics: implications for disease.
000116 (2017)	Stephen J. Kish [Canada] ; Isabelle Boileau [Canada] ; Russell C. Callaghan [Canada] ; Junchao Tong [Canada]	Brain dopamine neurone 'damage': methamphetamine users vs. Parkinson's disease - a critical assessment of the evidence.
000141 (2016)	Nicolas Morin ; Marc Morissette ; Laurent Grégoire ; Thérèse Di Paolo	mGlu5, Dopamine D2 and Adenosine A2A Receptors in L-DOPA-induced Dyskinesias
000199 (2016)	Panojot Bifsha [Canada] ; Aurelio Balsalobre [Canada] ; Jacques Drouin [Canada]	Specificity of Pitx3-Dependent Gene Regulatory Networks in Subsets of Midbrain Dopamine Neurons.
000207 (2016)	Kaviraja Udupa [Canada] ; Robert Chen [Canada]	Role of dopamine in motor cortex plasticity in Parkinson's disease.
000243 (2016)	Edith Miville-Godbout [Canada] ; Mélanie Bourque [Canada] ; Marc Morissette [Canada] ; Sara Al-Sweidi [Canada] ; Tara Smith [Canada] ; Asuka Mochizuki [Canada, Japon] ; Vijitha Senanayake [Canada] ; Dushmanthi Jayasinghe [Canada] ; Li Wang [Canada] ; Dayan Goodenowe [Canada] ; Thérèse Di Paolo [Canada]	Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice
000314 (2016)	F. Pieruccini-Faria [Canada] ; J A Jones [Canada] ; Q J Almeida [Canada]	Insight into dopamine-dependent planning deficits in Parkinson's disease: A sharing of cognitive & sensory resources.
000379 (2016)	Lucia Ricciardi [Royaume-Uni] ; Kristy J. Espay [États-Unis] ; Robert Krikorian [États-Unis] ; Alfonso Fasano [Canada] ; Alberto J. Espay [États-Unis]	Dopamine dysregulation syndrome with psychosis in 24-hour intestinal levodopa infusion for Parkinson's disease.
000380 (2016)	Mario Masellis [Canada] ; Shannon Collinson [Canada] ; Natalie Freeman [Canada] ; Maria Tampakeras [Canada] ; Joseph Levy [Israël] ; Amir Tchelet [Israël] ; Eli Eyal [Israël] ; Elijahu Berkovich [Israël] ; Rom E. Eliaz [Israël] ; Victor Abler [Israël] ; Iris Grossman [Israël] ; Cheryl Fitzer-Attas [Israël] ; Arun Tiwari [Canada] ; Michael R. Hayden [Israël] ; James L. Kennedy [Canada] ; Anthony E. Lang [Canada] ; Jo Knight [Royaume-Uni]	Dopamine D2 receptor gene variants and response to rasagiline in early Parkinson's disease: a pharmacogenetic study.
000429 (2016)	Serdar Durdagi [Turquie] ; Ramin Ekhteiari Salmas [Turquie] ; Matthias Stein [Allemagne] ; Mine Yurtsever [Turquie] ; Philip Seeman	Binding Interactions of Dopamine and Apomorphine in D2High and D2Low States of Human Dopamine D2 Receptor Using Computational and Experimental Techniques.
000454 (2016)	Dimitri Ryczko [Canada] ; Jackson J. Cone ; Michael H. Alpert ; Laurent Goetz [Canada] ; François Auclair [Canada] ; Catherine Dubé [Canada] ; Martin Parent [Canada] ; Mitchell F. Roitman ; Simon Alford ; Réjean Dubuc [Canada]	A descending dopamine pathway conserved from basal vertebrates to mammals
000470 (2015)	Doris E. Payer [Canada] ; Mark Guttman ; Stephen J. Kish ; Junchao Tong ; Antonio Strafella ; Martin Zack ; John R. Adams ; Pablo Rusjan ; Sylvain Houle ; Yoshiaki Furukawa ; Alan A. Wilson ; Isabelle Boileau	[¹¹C]-(+)-PHNO PET imaging of dopamine D(2/3) receptors in Parkinson's disease with impulse control disorders.
000524 (2015)	Paolo Solla [Italie] ; Alfonso Fasano [Canada] ; Antonino Cannas [Italie] ; Francesco Marrosu [Italie]	Suicide and dopamine agonist withdrawal syndrome in Parkinson's disease.
000536 (2015)	Philippe Huot [Canada] ; William D. Hutchison [Canada]	Serotonin/dopamine transporter ratio as a predictor of L-dopa-induced dyskinesia.
000542 (2015)	Tanja Tran [Canada] ; James M. Brophy [Canada] ; Samy Suissa [Canada] ; Christel Renoux [Canada]	Risks of Cardiac Valve Regurgitation and Heart Failure Associated with Ergot- and Non-Ergot-Derived Dopamine Agonist Use in Patients with Parkinson's Disease: A Systematic Review of Observational Studies.
000583 (2015)	Johanna M. Jarcho [États-Unis] ; Natasha A. Feier [États-Unis, Canada] ; Jennifer S. Labus [États-Unis] ; Bruce Naliboff [États-Unis] ; Suzanne R. Smith [États-Unis] ; Jui-Yang Hong [États-Unis] ; Luana Colloca [États-Unis] ; Kirsten Tillisch [États-Unis] ; Mark A. Mandelkern [États-Unis] ; Emeran A. Mayer [États-Unis] ; Edythe D. London [États-Unis]	Placebo analgesia: Self-report measures and preliminary evidence of cortical dopamine release associated with placebo response
000601 (2015)	Philip Seeman [Canada]	Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors.
000665 (2015)	Dayne A. Beccano-Kelly ; Mattia Volta ; Lise N. Munsie ; Sarah A. Paschall ; Igor Tatarnikov ; Kimberley Co ; Patrick Chou ; Li-Ping Cao ; Sabrina Bergeron ; Emma Mitchell ; Heather Han ; Heather L. Melrose [États-Unis] ; Lucia Tapia ; Lynn A. Raymond [Canada] ; Matthew J. Farrer ; Austen J. Milnerwood [Canada]	LRRK2 overexpression alters glutamatergic presynaptic plasticity, striatal dopamine tone, postsynaptic signal transduction, motor activity and memory.
000709 (2015)	Emily M. Rocha [États-Unis] ; Gaynor A. Smith [États-Unis] ; Eric Park [États-Unis] ; Hongmei Cao [États-Unis] ; Eilish Brown [États-Unis] ; Melissa A. Hayes [États-Unis] ; Jonathan Beagan [États-Unis] ; Jesse R. Mclean [États-Unis] ; Sarah C. Izen [États-Unis] ; Eduardo Perez-Torres [États-Unis] ; Penelope J. Hallett [États-Unis] ; Ole Isacson [États-Unis]	Glucocerebrosidase gene therapy prevents α-synucleinopathy of midbrain dopamine neurons.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "dopamine" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "dopamine" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    dopamine
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022